Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy
J. De Lemos, E. Braunwald, M. Blazing, S. Murphy, J. R. Downs, A. Gotto, M. Clearfield, H. Holdaas, D. Gordon, B. Davis, M. Koren, B. Dahlof, N. Poulter, P. Sever, R. H. Knopp, B. Fellström, H. Holdaas, A. Jardine, R. Schmieder, F. ZannadU. Goldbourt, E. Kaplinsky, H. M. Colhoun, D. J. Betteridge, P. N. Durrington, G. A. Hitman, J. Fuller, A. Neil, C. Wanner, V. Krane, F. Sacks, L. Moyé, M. Pfeffer, C. M. Hawkins, E. Braunwald, J. Kjekshus, H. Wedel, J. Wikstrand, L. Tavazzi, A. Maggioni, R. Marchioli, G. Tognoni, M. G. Franzosi, A. Maggioni, R. Collins, J. Armitage, A. Keech, S. Parish, R. Peto, P. Sleight, T. R. Pedersen, P. M. Ridker, J. Simes, A. Keech, S. MacMahon, I. Marschner, A. Tonkin, J. Shaw, P. W. Serruys, H. Nakamura, G. Knatterud, C. Furberg, R. Byington, P. Macfarlane, S. Cobbe, I. Ford, M. Murphy, G. J. Blauw, C. Packard, J. Shepherd, J. Kjekshus, T. Pedersen, L. Wilhelmsen, E. Braunwald, C. Cannon, S. Murphy, R. Collins, J. Armitage, L. Bowman, S. Parish, R. Peto, P. Sleight, J. La Rosa, J. Shepherd, S. Cobbe, P. Macfarlane, I. Ford, M. Flather, J. Kastelein, C. Newman, C. Shear, J. Tobert, J. Varigos, H. White, S. Yusuf, A. Baxter, C. Baigent, E. H. Barnes, N. Bhala, L. Blackwell, G. Buck, R. Collins, J. Emberson, W. G. Herrington, L. E. Holland, P. M. Kearney, A. Keech, A. Kirby, D. A. Lewis, I. Marschner, C. Reith, J. Simes, M. Mellies, M. McGovern, J. Barclay, R. Belder, Y. Mitchell, T. Musliner, J. C. Ansquer, M. Llewellyn, M. Bortolini, B. Bryzinski, G. Olsson, J. Pears, D. De Micco, Jonathan R. Emberson, Patricia M. Kearney, Lisa Blackwell, Connie Newman, Christina Reith, Neeraj Bhala, Lisa Holland, Richard Peto, Anthony Keech, Rory Collins, John Simes, Colin Baigent
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy'. Together they form a unique fingerprint.